Gastric Bleed

Patient presents with symptoms suggestive of a gastric bleed, including hematemesis, coffee-ground emesis, melena, and generalized weakness.  Onset of symptoms occurred approximately [timeframe] prior to presentation.  Patient reports [presence or absence] of abdominal pain, described as [character of pain] located in the [location of pain].  Associated symptoms include [list associated symptoms, e.g., nausea, dizziness, lightheadedness, syncope, shortness of breath].  Relevant medical history includes [list relevant medical history, e.g., peptic ulcer disease, NSAID use, history of GI bleeding, cirrhosis, portal hypertension, coagulopathy].  Medications include [list medications].  Physical examination reveals [vital signs, e.g., tachycardia, hypotension, orthostatic hypotension], [abdominal exam findings, e.g., tenderness to palpation, guarding, rigidity], and [other pertinent findings, e.g., pallor, diaphoresis].  Initial laboratory evaluation includes complete blood count (CBC) to assess for anemia, coagulation studies (PT/INR, PTT), comprehensive metabolic panel (CMP) to assess renal function and electrolyte balance, and type and screen in anticipation of possible transfusion.  Differential diagnosis includes peptic ulcer, gastritis, esophageal varices, Mallory-Weiss tear, and gastric cancer.  Given the clinical presentation concerning for upper gastrointestinal bleeding,  a stat gastroenterology consult has been requested for esophagogastroduodenoscopy (EGD) to visualize the upper GI tract and identify the source of bleeding.  Intravenous (IV) access has been established and fluid resuscitation with [type of fluid] has been initiated to maintain hemodynamic stability.  Patient is being closely monitored for signs of hemodynamic compromise.  Treatment plan will be further determined based on EGD findings and may include endoscopic hemostasis, pharmacologic therapy (e.g., proton pump inhibitors, octreotide), or surgical intervention if indicated.